Publications by authors named "Claudio Gasperini"

100Publications

Age-related adverse events of disease-modifying treatments for multiple sclerosis: A meta-regression.

Mult Scler 2020 Oct 26:1352458520964778. Epub 2020 Oct 26.

Department of Neurosciences, San Camillo-Forlanini Hospital, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458520964778DOI Listing
October 2020

EBV-specific CD8 T lymphocytes and B cells during glatiramer acetate therapy in patients with MS.

Neurol Neuroimmunol Neuroinflamm 2020 Nov 17;7(6). Epub 2020 Aug 17.

From the Neuroimmunology Unit (G.G., S.R., M.P., E.P., F.G., R.P., B.L., G.B., D.F.A.), IRCSS Fondazione Santa Lucia, Rome; Department of Neurosciences (C.G.), San Camillo-Forlanini Hospital, Rome; Department of Neurosciences, Mental Health, and Sensory Organs (NESMOS) (M.S., M.C.B.), Center for Experimental Neurological Therapies, S. Andrea Hospital-site, "Sapienza" University of Rome; and Neurological Institute (M.S.), NEUROMED, Molise, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000876DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455312PMC
November 2020

Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis.

J Neurol Neurosurg Psychiatry 2020 03 23;91(3):271-277. Epub 2020 Jan 23.

Multiple Sclerosis Center, San Camillo-Forlanini Hospital, Roma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp-2019-322348DOI Listing
March 2020

SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis.

Neuroimage Clin 2019 22;24:102011. Epub 2019 Oct 22.

Queen Square MS Centre, University College London, London, United Kingdom; National Institute of Health Research (NIHR), University College London Hospitals, Biomedical Research Centre, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nicl.2019.102011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861587PMC
September 2020

Single-subject structural cortical networks in clinically isolated syndrome.

Mult Scler 2020 Oct 24;26(11):1392-1401. Epub 2019 Jul 24.

Centre for Medical Image Computing (CMIC), UCL Medical Physics and Biomedical Engineering, University College London, London, UK/NIHR University College London Hospitals Biomedical Research Centre, London, UK/Alzheimer Center Amsterdam, Department of Neurology, Amsterdam University Medical Centers, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands/UCL Institute of Healthcare Engineering and UCL Queen Square Institute of Neurology, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458519865739DOI Listing
October 2020

Effect of dalfampridine on information processing speed impairment in multiple sclerosis.

Neurology 2019 08 22;93(8):e733-e746. Epub 2019 Jul 22.

From the MS Center Sant'Andrea Hospital (L.D.G., F.G., G.B., C.P.), Department of Human Neuroscience (L.D.G., F.D.L., F.G., I.F., C.P.), and Department of Psychology (F.D.L.), Sapienza University of Rome; Department of Neuroscience San Camillo-Forlanini Hospital (L.P., E.Q., C.G.); and Neurological Center of Latium (G.B.), IRCCS Neuromed, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000007970DOI Listing
August 2019

"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study.

Neurology 2019 05 1;92(22):e2527-e2537. Epub 2019 May 1.

From the Departments of Neuroscience, Biomedicine and Movement (M.C., A. Gajofatto) and Neurological and Movement Sciences (G.S.), University of Verona; Department of Neurosciences (C.G., C.T.), Azienda Ospedaliera San Camillo Forlanini, Roma; Department of Basic Medical Sciences, Neurosciences and Sense Organs (C.T., D.P.), University of Bari; Policlinico Gemelli (G.F.), Rome; Dipartimento di Biomedicina Sperimentale e Neuroscienze Cliniche (BIONEC) (P.R.), Università di Palermo; Istituto Neurologico Mediterraneo (R.F.), Pozzilli; Department of Neurology and Psychiatry (L.P.), Sapienza University of Rome; Multiple Sclerosis Center (P.A.), ASST Valle Olona, PO di Gallarate; Multiple Sclerosis Center (C.C.), Ospedale di Montichiari, Spedali Civili di Brescia; Clinica Neurologica (M.D.), Dipartimento di Medicina, Università di Perugia; Department of Biomedical, Metabolic and Neurosciences (D.F.), University of Modena and Reggio Emilia, Modena; Neurologia 2-CRESM (S.M.), AOU San Luigi Gonzaga, Orbassano; Multiple Sclerosis Centre (S.L.), A.O.U. Policlinico-Vittorio Emanuele, Catania; Neurology Clinic (G.D.), Multiple Sclerosis Center, SS. Annunziata Hospital, Chieti; Department of Medicine, Surgery and Neuroscience (M.L.S.), University of Siena; Department of Medical Science and Public Health (E.C.), University of Cagliari; Department of Medical, Surgical, Neurological, Metabolic and Aging Science (A. Gallo), University of Campania; Department of Neuroscience, Reproductive Sciences (R.L.), University Federico II, Naples, Italy; Institute of Psychological Medicine and Clinical Neurosciences (V.T.), Cardiff University School of Medicine, UK; Ospedale di Vaio (I.P.), Centro SM, Fidenza, Parma; Ospedale San Raffaele (M.E.R.), Milan; and Department of Rehabilitation (C.S.), Mons L Novarese Hospital, Moncrivello, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000007573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659006PMC
May 2019

How much do periventricular lesions assist in distinguishing migraine with aura from CIS?

Neurology 2019 04 8;92(15):e1739-e1744. Epub 2019 Mar 8.

From the Departments of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Maternal and Child Health (C.L., G.B., M.P., L.B., G.L.M., M.I.), University of Genoa; Departments of Neuroradiology (L.S., L.R.), Health Sciences (M.P.S., L.R.), and Neurology (M.P., G.L.M., M.I.), Ospedale Policlinico San Martino IRCCS, Genoa; Department of Neurosciences (C.G.), S. Camillo-Forlanini Hospital, Rome; and Departments of Medicine, Surgery, and Neuroscience (A.G., N.D.S.), University of Siena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000007266DOI Listing
April 2019

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.

Neurology 2019 01 26;92(4):180-192. Epub 2018 Dec 26.

From the Department of Neurosciences (C.G., L.P.), San Camillo-Forlanini Hospital, Rome, Italy; Centre d'Esclerosi Multiple de Catalunya (Cemcat), Department of Neurology/Neuroimmunology (M.T., J.R., J.S.-G., X.M.), and Magnetic Resonance Unit, Department of Radiology (A.R.), Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, Spain; Biostatistics Unit (M.P.S.), Department of Health Sciences, University of Genoa; Neuroimaging Research Unit (M.F., M.A.R.), Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy; Nuffield Department of Clinical Neurosciences (J.P.), West Wing, John Radcliffe Hospital, Oxford; Institutes of Neurology & Healthcare Engineering (O.C., F.B.), University College London (O.C.), UK; Amsterdam Neuroscience and Department of Radiology and Nuclear Medicine (F.B., H.V.), VU University Medical Center, Amsterdam, the Netherlands; Department of Neurology (J.L.F.), Rigshospitalet Glostrup and University of Copenhagen, Denmark; Neuroradiological Academic Unit (T.A.Y.), Institute of Neurology, London, UK; Department of Neurology (C.E.), Medical University of Graz, Austria; Neurologic Clinic and Policlinic, Department of Medicine (L.K.), Clinical Research, Biomedicine and Biomedical Engineering, University Hospital Basel, University of Basel, Switzerland; Department of Neurology and Psychiatry (C.P.), Sapienza University, Rome; and Neurology and Neurometabolic Unit, Department of Neurological and Behavioral Sciences (N.D.S.), University of Siena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000006810DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345120PMC
January 2019

Early transient asymptomatic neutropenia associated with alemtuzumab treatment in multiple sclerosis: a case report.

J Neurol 2018 Sep 17;265(9):2152-2153. Epub 2018 Jul 17.

MS Centre, Department of Neurosciences, S. Camillo-Forlanini Hospital, c.ne Gianicolense 87, 00152, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-018-8976-7DOI Listing
September 2018

Three-Tesla MRI does not improve the diagnosis of multiple sclerosis: A multicenter study.

Neurology 2018 07 20;91(3):e249-e257. Epub 2018 Jun 20.

From the Departments of Neurology (M.H.J.H., J.B., J.K.) and Radiology and Nuclear Medicine (I.D.K., M.L.d.V., M.P.W., F.B.), MS Centre Amsterdam, and Department of Epidemiology and Biostatistics (B.I.L.-W.), VU University Medical Centre; Department of Radiology and Nuclear Medicine (I.D.K.), Onze Lieve Vrouwen Gasthuis, Amsterdam, the Netherlands; Queen Square Multiple Sclerosis Centre (N.C., O.C.) and Institutes of Neurology & Healthcare Engineering (F.B.), UCL Institute of Neurology, London, UK; Department of Neurology and Psychiatry (E.S., P.P.), Sapienza University of Rome, Italy; Department of Neurology (M. Andelova, M. Amann) and Division of Neuroradiology, Department of Radiology (M. Amann, J.M.L.), University Hospital Basel; Medical Image Analysis Centre (M. Amann), Basel, Switzerland; Istituto Neurologico Mediterraneo (P.P.), Neuromed, Pozzilli (IS), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain; National Institute for Health Research (O.C., F.B.), University College London Hospitals (UCLH) Biomedical Research Centre (BRC), UK; Department of Neurosciences (C.G.), San Camillo-Forlanini Hospital, Rome, Italy; and Department of Diagnostic and Interventional Radiology and Nuclear Medicine (C.L.), St. Josef Hospital, Ruhr University, Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000005825DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059032PMC
July 2018

Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study.

Neurology 2018 07 6;91(2):e153-e161. Epub 2018 Jun 6.

From the Department of Neurosciences (L.P., S.H., S.G., C.G., S.R.), S. Camillo-Forlanini Hospital; Department of Neurology and Psychiatry (A.C., L.D.G., A. Francia, E.M., S.P., C.P., S.R., E.S.), Sapienza University; Fondazione Policlinico Universitario IRCCS "A. Gemelli" (M.L., A.B., V.N., M.M.), Università Cattolica del Sacro Cuore, Rome; Unit of Neurology and of Neurorehabilitation (P.B., F.B., D.C., R.F., M.S.), IRCCS Neuromed, Pozzilli (IS); Center for Experimental Neurological Therapies (M.C.B., A. Fornasiero, M.S.), S. Andrea Hospital, Deptartment of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome; Department of Systems Medicine (F.B., D.C., G.A.M.), MS Clinical and Research Center, Tor Vergata University; Neurology Unit (E.F.), S. Filippo Neri Hospital, Rome; and Don Carlo Gnocchi Foundation Onlus (V.N.), Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000005772DOI Listing
July 2018

Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation.

Sci Rep 2018 01 22;8(1):1319. Epub 2018 Jan 22.

Department of Psychological, Health and Territorial Sciences, School of Medicine and Health Sciences, "G.d'Annunzio" University, Via Dei Vestini 31, 66100, Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-19701-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778050PMC
January 2018

Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.

Lancet Neurol 2018 02 21;17(2):133-142. Epub 2017 Dec 21.

Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy; Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(17)30469-6DOI Listing
February 2018

Anti lingo 1 (opicinumab) a new monoclonal antibody tested in relapsing remitting multiple sclerosis.

Expert Rev Neurother 2017 Nov 15;17(11):1081-1089. Epub 2017 Sep 15.

b Department of Neurosciences , S Camillo Forlanini Hospital , Rome , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737175.2017.1378098DOI Listing
November 2017

A Comprehensive Review on Copemyl.

Neurol Ther 2017 Dec 31;6(2):161-173. Epub 2017 Jul 31.

Multiple Sclerosis Study Center, ASST Valle Olona, Gallarate, VA, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40120-017-0079-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700901PMC
December 2017

A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band.

J Neurol 2017 May 5;264(5):973-978. Epub 2017 Apr 5.

Neurology Unit, Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Nuovo Ospedale Civile Sant'Agostino Estense, Via Pietro Giardini, 1355, 41126, Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-017-8480-5DOI Listing
May 2017

Dysregulated Homeostasis of Acetylcholine Levels in Immune Cells of RR-Multiple Sclerosis Patients.

Int J Mol Sci 2016 Nov 30;17(12). Epub 2016 Nov 30.

Department of Biology and Biotechnologies Charles Darwin, Research, Center of Neurobiology Daniel Bovet, Sapienza University of Rome, 00185 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms17122009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187809PMC
November 2016

Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple Sclerosis.

Mol Neurobiol 2017 11 8;54(9):7520-7533. Epub 2016 Nov 8.

Institute of Biochemistry and Clinical Biochemistry, Catholic University of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12035-016-0257-9DOI Listing
November 2017

Assessing response to interferon-β in a multicenter dataset of patients with MS.

Neurology 2016 Jul 15;87(2):134-40. Epub 2016 Jun 15.

From the University of Genoa (M.P.S.); Hospital San Camillo Forlanini (C.G.) and Department of Neurology and Psychiatry (L.P., C.P.), Sapienza University, Rome; Department of Neurology (M.R., V.M., G.C.) and Neuroimaging Research Unit (M.A.R., M.F.), San Raffaele Scientific Institute, Milan, Italy; Hospital Universitario Vall d'Hebron (J.R., M. Tintorè, A.R., X.M.), Barcelona, Spain; University of Verona (M.C.); Department of Public Health, Clinical and Molecular Medicine (E.C.), and Department of Medical Sciences (M.G.M., E.C.), University of Cagliari, Italy; Department of Neurology (C.E., F.F.), Medical University of Graz, Austria; Dip. to di Scienze Mediche, Chirurgiche, Neurologiche, Metaboliche e dell'Invecchiamento (A.G., G.T.), Seconda Universita' di Napoli, MRI Research Center "SUN-FISM," Hermitage-Capodimonte Clinic, Naples, Italy; Neurology (L.K., T.S.), Departments of Medicine, Clinical Research, and Biomedical Engineering, University Hospital Basel, Switzerland; DKD Helios Klinik Wiesbaden (T.S.), Germany; University of Siena (M.L.S., N.D.S.); and Department of Medical Sciences, Neurosciences and Sense Organs (M. Trojano, C.T.), University of Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000002830DOI Listing
July 2016

Visual pathway neurodegeneration winged by mitochondrial dysfunction.

Ann Clin Transl Neurol 2015 Feb 17;2(2):140-50. Epub 2014 Dec 17.

Molecular Cell Biology and Immunology, VU University Medical Center Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acn3.157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338955PMC
February 2015

Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.

Mult Scler 2015 Nov 19;21(13):1713-22. Epub 2015 Feb 19.

Department of Neurology and Psychiatry, Sapienza University, ItalyMS Centre, S. Antonio Abate Hospital, ItalyNeurologia 2 - CRESM (Centro Riferimento Regionale Sclerosi Multipla), University Hospital San Luigi Gonzaga, ItalyRegional Referring MS Center, Spedali Civili of Brescia, Montichiari Hospital, ItalyDepartment of Neurosciences Tor Vergata University, Italy/IRCCS Neuromed, ItalyDepartment of Neurosciences, S. Camillo-Forlanini Hospital, ItalyDepartment of Neurosciences, S. Camillo-Forlanini Hospital, ItalyNeurology Unit, Department Head and Neck, ASL 3 genovese, Genova, ItalyDepartment of Neurosciences Tor Vergata University, Italy/S. Lucia Foundation IRCCS, ItalyNeurologia 2 - CRESM (Centro Riferimento Regionale Sclerosi Multipla), University Hospital San Luigi Gonzaga, ItalyDepartment of Neurology and Psychiatry, Sapienza University, ItalyMS Centre, S. Antonio Abate Hospital, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458515570768DOI Listing
November 2015

Serum lactate as a novel potential biomarker in multiple sclerosis.

Biochim Biophys Acta 2014 Jul 13;1842(7):1137-43. Epub 2014 Apr 13.

Institute of Biochemistry and Clinical Biochemistry Largo F. Vito 1, 00168 Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2014.04.005DOI Listing
July 2014

Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis.

Ther Clin Risk Manag 2014 27;10:229-39. Epub 2014 Mar 27.

Department of Neurosciences, S Camillo Forlanini Hospital, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/TCRM.S53285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972027PMC
June 2014

CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes.

Immunol Lett 2014 Mar-Apr;158(1-2):134-42. Epub 2014 Jan 8.

Istituto Pasteur-Fondazione Cenci Bolognetti, Department of Biology and Biotechnology Charles Darwin, Sapienza University, Via dei sardi 70, 00185 Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imlet.2013.12.020DOI Listing
November 2014

Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.

Neurology 2014 Jan 4;82(1):41-8. Epub 2013 Dec 4.

From the Center for Experimental Neurological Therapies (G.R., S.R., S.C., A.V., C.B., G.C., M.S.), S. Andrea Hospital-site, Neurosciences, Mental Health, and Sensory Organs (NESMOS) Department and Department of Neurology and Psychiatry (E.T., M.F., C.P.), "Sapienza" University of Rome, Department of Neurological Sciences (C.G.), Azienda Ospedaliera S Camillo-Forlanini, Rome; MSCenter (L.M., D.C.) and Neuroradiology Unit (P.C.), Fondazione don Carlo Gnocchi, IRCCS, Milan; Department of Neurological Sciences (R.L., V.B.), Federico II University, and Biostructure and Bioimaging Institute (M.Q.), CNR, Naples; and National Centre of Epidemiology (N.V.), National Institute of Health, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.wnl.0000438216.93319.abDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873620PMC
January 2014

Efficacy and safety of laquinimod in multiple sclerosis: current status.

Ther Adv Neurol Disord 2013 Nov;6(6):343-52

Multiple Sclerosis Clinical Centre, Department of Neurosciences, San Camillo Forlanini Hospital, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756285613499424DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825117PMC
November 2013

Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.

Expert Opin Investig Drugs 2013 Oct 16;22(10):1243-53. Epub 2013 Jul 16.

Multiple Sclerosis Center, S Camillo-Forlanini, Neurosciences , Circonvallazione Gianicolense 87, Rome 00152 , Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2013.820275DOI Listing
October 2013

Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimod.

Ther Clin Risk Manag 2013 3;9:73-85. Epub 2013 Mar 3.

Department of Neurosciences, S Camillo Forlanini Hospital, Rome, Italy;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/TCRM.S17426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590932PMC
March 2013

Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach.

Drug Des Devel Ther 2012 19;6:175-86. Epub 2012 Jul 19.

Department of Neurosciences, S Camillo Forlanini Hospital, University of Rome Sapienza, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DDDT.S8927DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414371PMC
October 2012

Emerging oral drugs for relapsing-remitting multiple sclerosis.

Expert Opin Emerg Drugs 2011 Dec 7;16(4):697-712. Epub 2011 Dec 7.

Dipartimento Testa Collo, Azienda Ospedaliera S. Camillo-Forlanini, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728214.2011.642861DOI Listing
December 2011

Efficacy and safety of subcutaneous interferon β-1a in relapsing-remitting multiple sclerosis: further outcomes from the IMPROVE study.

J Neurol Sci 2012 Jan 31;312(1-2):97-101. Epub 2011 Aug 31.

Department of Neurological and Behavioral Sciences, University of Siena, Siena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2011.08.013DOI Listing
January 2012

Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis.

Mult Scler 2012 Jan 9;18(1):64-71. Epub 2011 Aug 9.

Department of Neurology and Psychiatry, Multiple Sclerosis Centre, S. Andrea Hospital, Sapienza University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458511417481DOI Listing
January 2012

Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tablets.

Ther Clin Risk Manag 2010 Sep 7;6:391-9. Epub 2010 Sep 7.

Department of Neurosciences, S Camillo Forlanini Hospital, Rome, Italy;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940747PMC
http://dx.doi.org/10.2147/tcrm.s6639DOI Listing
September 2010

Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis.

Mult Scler 2010 Jul 3;16(7):888-92. Epub 2010 Mar 3.

Department of Neurological and Behavioral Sciences, University of Siena, Siena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458510362442DOI Listing
July 2010

New oral drugs for multiple sclerosis.

Neurol Sci 2009 Oct;30 Suppl 2:S179-83

Centro Sclerosi Multipla, Azienda Ospedaliera S. Camillo-Forlanini, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10072-009-0146-3DOI Listing
October 2009

Emerging oral drugs for multiple sclerosis.

Expert Opin Emerg Drugs 2008 Sep;13(3):465-77

S Camillo-Forlanini Hospital, Department of Neuroscience, Viale dell'Università 30, 00185 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728214.13.3.465DOI Listing
September 2008

Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years.

J Neurol Sci 2003 Nov;215(1-2):3-8

Department of Experimental Medicine and Pathology, Section of Virology, University "La Sapienza", V.le di Porta Tiburtina 28, 00185 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0022-510x(03)00173-4DOI Listing
November 2003

Proteolytic balance in patients with multiple sclerosis during interferon treatment.

J Interferon Cytokine Res 2002 Jun;22(6):689-92

Department of Internal Medicine, Immunology, and Infectious Diseases, Section of Internal Medicine, University of Bari Medical School, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/10799900260100187DOI Listing
June 2002